ArticleCost effectiveness and resource allocation : C/E2009
Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia.
Article in Cost effectiveness and resource allocation : C/E, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries.Bulletin of the World Health Organization · 2014Pooled it
- Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries.PharmacoEconomics · 2011Pooled it
- Article
- Article
- Assessing the cost of providing a prevention of mother-to-child transmission of HIV/AIDS service in Ethiopia: urban-rural health facilities setting.BMC health services research · 2019Article
- Costs incurred by outpatients at a university hospital in northwestern Ethiopia: a cross-sectional study.BMC health services research · 2018Article
- Article
- Annual cost of antiretroviral therapy among three service delivery models in Uganda.Journal of the International AIDS Society · 2016Article
- The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource Settings.PloS one · 2015Article
- Article
- Scaling up integrated prevention campaigns for global health: costs and cost-effectiveness in 70 countries.BMJ open · 2014Article
- The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina Faso.PloS one · 2014Article
- Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia.PloS one · 2012Article
- Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation.PLoS medicine · 2012Article
- The cost of providing comprehensive HIV treatment in PEPFAR-supported programs.AIDS (London, England) · 2011Article
- Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia.Cost effectiveness and resource allocation : C/E · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLittle is known about the costs of HIV care in Ethiopia.
objectiveTo estimate the average per person year (PPY) cost of care for HIV patients with and without anti-retroviral therapy (ART) in a district hospital.
methodsData on costs and utilization of HIV-related services were taken from Arba Minch Hospital (AMH) in southern Ethiopia. Mean annual outpatient and inpatient costs and corresponding 95% confidence intervals (CI) were calculated. We adopted a district hospital perspective and focused on hospital costs.
findingsPPY average (95% CI) costs under ART were US$235.44 (US$218.11-252.78) and US$29.44 (US$24.30-34.58) for outpatient and inpatient care, respectively. Estimates for the non-ART condition were US$38.12 (US$34.36-41.88) and US$80.88 (US$63.66-98.11) for outpatient and inpatient care, respectively. The major cost driver under the ART scheme was cost of ART drugs, whereas it was inpatient care and treatment in the non-ART scheme.
conclusionThe cost profile of ART at a district hospital level may be useful in the planning and budgeting of implementing ART programs in Ethiopia. Further studies that focus on patient costs are warranted to capture all patterns of service use and relevant costs. Economic evaluations combining cost estimates with clinical outcomes would be useful for ranking of ART services.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.